查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1820203

子宫颈癌诊断市场报告，按检测类型（巴氏抹片检查、HPV 检测、子宫颈活检、阴道镜检查等）、年龄组（20 至 35 岁、35 岁以上）和地区划分，2025 年至 2033 年

Cervical Cancer Diagnostics Market Report by Test Type (Pap Testing, HPV Testing, Cervical Biopsies, Colposcopy, and Others), Age Group (20 to 35 Years, Above 35 Years), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

2024年全球子宫颈癌诊断市场规模达83亿美元。展望未来， IMARC Group预计到2033年市场规模将达到127亿美元，2025-2033年期间的成长率（CAGR）为4.56%。

子宫颈癌诊断依赖一系列先进的实验室检测、工具和程序来评估人类乳突病毒 (HPV) 的异常细胞或病毒株。诊断过程包括：取子宫颈锥切术、穿刺切片、子宫颈管刮除术及电热环套扎术等组织样本，在阴道镜检查期间进行子宫颈的全面检查。检查结束后，也会进行血液检查、胸部 X 光检查、全身电脑断层扫描 (CT)、磁振造影 (MRI)、正子断层扫描 (PET) 以及膀胱和直肠的目视检查，以确定疾病分期。

被诊断患有梅毒、披衣菌、淋病和后天免疫缺乏症候群（HIV/AIDS）等性传染感染 (STI) 的人数大幅增加，导致全球 HPV 感染风险不断上升。此外，吸烟者人数不断增加也增加了罹患子宫颈癌的风险，这些因素共同构成了推动市场成长的关键因素之一。此外，人们对早期诊断认识的不断提高，也促使人们开始使用能够快速且准确地检测结果的 HPV 家用检测试剂盒。优惠的报销政策也支持了市场的成长。此外，人们对个人化治疗方案的偏好日益增长，也推动了子宫颈癌诊断的需求。此外，包括手术、放射疗法、化疗、锥形活检、免疫疗法和子宫颈切除术在内的一系列其他治疗方案的出现，也促进了市场的成长。此外，对开发低成本高效检测产品的日益重视预计将推动市场的成长。

本报告回答的关键问题

  • 全球子宫颈癌诊断市场有多大？ 2025-2033年全球子宫颈癌诊断市场的预期成长率是多少？
  • 推动全球子宫颈癌诊断市场发展的关键因素有哪些？
  • COVID-19 对全球子宫颈癌诊断市场有何影响？
  • 根据检测类型，全球子宫颈癌诊断市场是如何分布的？
  • 全球子宫颈癌诊断市场的主要地区有哪些？
  • 全球子宫颈癌诊断市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 二手资料
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球子宫颈癌诊断市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依测试类型

  • 巴氏抹片检查
  • HPV检测
  • 子宫颈活检
  • 阴道镜检查
  • 其他的

第七章：市场区隔：依年龄段

  • 20至35岁
  • 35岁以上

第八章：市场区隔：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第九章：SWOT分析

第 10 章：价值链分析

第 11 章：波特五力分析

第 12 章：价格分析

第 13 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Arbor Vita Corporation
    • Becton, Dickinson and Company
    • Cooper Surgical Inc.
    • F. Hoffmann-La Roche AG
    • Guided Therapeutics Inc.
    • Hologic Inc.
    • Qiagen
    • Quest Diagnostics Incorporated
    • Siemens Healthcare GmbH
Product Code: SR112025A3175

The global cervical cancer diagnostics market size reached USD 8.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 12.7 Billion by 2033, exhibiting a growth rate (CAGR) of 4.56% during 2025-2033.

Cervical cancer diagnostics rely on a series of advanced laboratory tests, tools and procedures to evaluate abnormal cells or strains of the human papillomavirus (HPV). They are performed by taking a sample of the tissue obtained through conization, punch biopsy, endocervical curettage and the electrical wire loop for a thorough examination of the cervix during colposcopy. After detection, tests like blood, chest X-ray, body computed tomography (CT) scan, magnetic resonance imaging (MRI), positron emission tomography (PET) scan and visual examination of bladder and rectum are conducted to determine the disease stage.

A considerable rise in the number of individuals diagnosed with sexually transmitted infections (STIs), such as syphilis, chlamydia, gonorrhea and acquired immune deficiency syndrome (HIV/AIDS), is escalating the risk of HPV infection worldwide. This, along with the growing number of smokers, which increases the chances of developing cervical cancer, represents one of the key factors bolstering the market growth. Furthermore, the rising awareness about early diagnosis is encouraging the adoption of HPV home testing kits that provide quick and accurate test results. The presence of favorable reimbursement policies also supports the market growth. Apart from this, rising preferences for personalized treatment plans are escalating the demand for cervical cancer diagnostics. Additionally, the availability of a range of other treatment options, including surgery, radiation therapy, chemotherapy, cone biopsy, immunotherapy and trachelectomy, is contributing to the market growth. Moreover, the growing emphasis on developing low-cost and efficient testing products is anticipated to fuel the market growth.

Key Market Segmentation:

Breakup by Test Type:

  • Pap Testing
  • HPV Testing
  • Cervical Biopsies
  • Colposcopy
  • Others

Breakup by Age Group:

  • 20 to 35 years
  • Above 35 years

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arbor Vita Corporation, Becton, Dickinson and Company, Cooper Surgical Inc., F. Hoffmann-La Roche AG, Guided Therapeutics Inc., Hologic Inc., Qiagen, Quest Diagnostics Incorporated and Siemens Healthcare GmbH.

Key Questions Answered in This Report

  • 1.How big is the global cervical cancer diagnostics market?
  • 2.What is the expected growth rate of the global cervical cancer diagnostics market during 2025-2033?
  • 3.What are the key factors driving the global cervical cancer diagnostics market?
  • 4.What has been the impact of COVID-19 on the global cervical cancer diagnostics market?
  • 5.What is the breakup of the global cervical cancer diagnostics market based on the test type?
  • 6.What are the key regions in the global cervical cancer diagnostics market?
  • 7.Who are the key players/companies in the global cervical cancer diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cervical Cancer Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Test Type

  • 6.1 Pap Testing
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 HPV Testing
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Cervical Biopsies
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Colposcopy
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Age Group

  • 7.1 20 to 35 years
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Above 35 years
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Arbor Vita Corporation
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Becton, Dickinson and Company
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Cooper Surgical Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 F. Hoffmann-La Roche AG
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Guided Therapeutics Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 SWOT Analysis
    • 13.3.7 Hologic Inc.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Qiagen
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Quest Diagnostics Incorporated
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Siemens Healthcare GmbH
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 SWOT Analysis

List of Figures

  • Figure 1: Global: Cervical Cancer Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Cervical Cancer Diagnostics Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Cervical Cancer Diagnostics Market: Breakup by Test Type (in %), 2024
  • Figure 5: Global: Cervical Cancer Diagnostics Market: Breakup by Age Group (in %), 2024
  • Figure 6: Global: Cervical Cancer Diagnostics Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Cervical Cancer Diagnostics (Pap Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Cervical Cancer Diagnostics (Pap Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Cervical Cancer Diagnostics (HPV Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Cervical Cancer Diagnostics (HPV Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Cervical Cancer Diagnostics (Cervical Biopsies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Cervical Cancer Diagnostics (Cervical Biopsies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Cervical Cancer Diagnostics (Colposcopy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Cervical Cancer Diagnostics (Colposcopy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Cervical Cancer Diagnostics (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Cervical Cancer Diagnostics (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Cervical Cancer Diagnostics (20 to 35 years) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Cervical Cancer Diagnostics (20 to 35 years) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Cervical Cancer Diagnostics (Above 35 years) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Cervical Cancer Diagnostics (Above 35 years) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: North America: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: North America: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: United States: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: United States: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Canada: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Canada: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Asia-Pacific: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Asia-Pacific: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: China: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: China: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Japan: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Japan: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: India: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: India: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: South Korea: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: South Korea: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Australia: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Australia: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Indonesia: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Indonesia: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Others: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Others: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Europe: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Europe: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Germany: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Germany: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: France: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: France: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: United Kingdom: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: United Kingdom: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Italy: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Italy: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Spain: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Spain: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Russia: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Russia: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Others: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Others: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Latin America: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Latin America: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Brazil: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Brazil: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Mexico: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Mexico: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Others: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Others: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Middle East and Africa: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Middle East and Africa: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Middle East and Africa: Cervical Cancer Diagnostics Market: Breakup by Country (in %), 2024
  • Figure 70: Global: Cervical Cancer Diagnostics Industry: SWOT Analysis
  • Figure 71: Global: Cervical Cancer Diagnostics Industry: Value Chain Analysis
  • Figure 72: Global: Cervical Cancer Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cervical Cancer Diagnostics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Cervical Cancer Diagnostics Market Forecast: Breakup by Test Type (in Million USD), 2025-2033
  • Table 3: Global: Cervical Cancer Diagnostics Market Forecast: Breakup by Age Group (in Million USD), 2025-2033
  • Table 4: Global: Cervical Cancer Diagnostics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Cervical Cancer Diagnostics Market: Competitive Structure
  • Table 6: Global: Cervical Cancer Diagnostics Market: Key Players